Enucleation for benign or borderline tumors of the pancreas: comparing open and minimally invasive surgery

Background - The feasibility and safety of minimally invasive enucleation (ME) for benign or borderline pancreatic tumors is still unclear. The aim of this study was to compare outcomes between ME and open enucleation (OE). - Methods - All patients undergoing pancreatic enucleation between October 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ei, Shigenori (VerfasserIn) , Mihaljevic, André Leopold (VerfasserIn) , Kulu, Yakup (VerfasserIn) , Kaiser, Jörg (VerfasserIn) , Hinz, Ulf (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Hackert, Thilo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: HPB
Year: 2021, Jahrgang: 23, Heft: 6, Pages: 921-926
ISSN:1477-2574
DOI:10.1016/j.hpb.2020.10.001
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.hpb.2020.10.001
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1365182X20311874
Volltext
Verfasserangaben:Shigenori Ei, André L. Mihaljevic, Yakup Kulu, Joerg Kaiser, Ulf Hinz, Markus W. Büchler, Thilo Hackert
Beschreibung
Zusammenfassung:Background - The feasibility and safety of minimally invasive enucleation (ME) for benign or borderline pancreatic tumors is still unclear. The aim of this study was to compare outcomes between ME and open enucleation (OE). - Methods - All patients undergoing pancreatic enucleation between October 2001 and January 2020 were analyzed from a prospective database. Consecutive patients undergoing ME were compared with patients undergoing OE in a matched-pair analysis (1:2). - Results - Of 358 patients, undergoing enucleation, 120 matched patients (ME n = 40, OE n = 80) were included. Patients undergoing ME had less blood loss (median 50 vs. 100 ml, P = 0.025) and had a higher proportion of patients discharged by 7 days, than patients undergoing OE (38% vs. 18%, P = 0.016). The rates of clinically relevant postoperative pancreatic fistula (POPF) and major complications (Clavien grade ≥ 3) were similar between both groups. Risk factor analysis for POPF B/C showed no significant parameters associated with POPF, including tumor size and proximity to the main pancreatic duct. - Conclusion - Compared with conventional OE, ME reduces the amount of bleeding and allows earlier postoperative discharge, without increasing the incidence of major complications. Thus, minimally invasive enucleation should be considered for benign tumors of the pancreas when technically and oncologically feasible.
Beschreibung:Available online 18 October 2020
Gesehen am 09.07.2021
Beschreibung:Online Resource
ISSN:1477-2574
DOI:10.1016/j.hpb.2020.10.001